A compound with the SMILES O=C(CN1C(=O)NC2(CCCC2)C1=O)Nc1cc(S(=O)(=O)N2CCOCC2)ccc1OCC(F)(F)F has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 6.578%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
O=C(CN1C(=O)NC2(CCCC2)C1=O)Nc1cc(S(=O)(=O)N2CCOCC2)ccc1OCC(F)(F)F
O=C(CN1C(=O)NC2(CCCC2)C1=O)Nc1cc(S(=O)(=O)N2CCOCC2)ccc1OCC(F)(F)F
2-(2,4-dioxo-1,3-diazaspiro[4.4]nonan-3-yl)-N-[5-morpholin-4-ylsulfonyl-2-(2,2,2-trifluoroethoxy)phenyl]acetamide